The role of preoperative immune cell metrics in renal cell carcinoma with a tumor thrombus.
Maxwell SandbergMary NamugosaRory RittsClaudia Marie CostaDavis TempleMitchell HayesWyatt WhitmanEmily YeJustin Manuel RefugiaReuben Ben-DavidParissa AlerasoolBenjamin EilenderRafael Ribeiro ZanottiThiago Camelo MourãoJung Kwon KimPatricio Garcia MarchiñenaSeok-Soo ByunDiego AbreuReza MehrazinPhilippe SpiessStenio de Cassio ZequiAlejandro RodriguezPublished in: Urologia (2024)
Preoperative immune metrics have clinical utility in predicting cancer-specific outcomes for patients with RCC and a tumor thrombus. Additional study is needed to determine the added value of preoperative serum immune cell data to established prognostic risk calculators for this patient population.